LOEWS CORPLOEWS CORP

Institutional investor · Portfolio as of Q2 2023

Top Holdings31 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

CNA FINL CORP

244M$9.4B96.9%$25.30+18.46%
18 qtrssince 2019-Q1
Increased
63
BERYBERYDelisted

BERRY GLOBAL GROUP INC

416,000$26.8M0.3%
16 qtrssince 2019-Q3
Decreased
0

AIR PRODUCTS & CHEMICALS INC

70,000$21M0.2%$225.64+21.67%
13 qtrssince 2020-Q2
Unchanged
0
HBIHBIAcquired

HANESBRANDS INC

4.4M$20M0.2%
2 qtrssince 2023-Q1
Increased
44

INGREDION INCORPORATED

185,000$19.6M0.2%$71.15+36.84%
16 qtrssince 2019-Q3
Decreased
0

LYONDELLBASELL INDU-CL A

210,000$19.3M0.2%$69.22+9.83%
18 qtrssince 2019-Q1
Increased
39

HCA HOLDINGS INC

57,500$17.5M0.2%$171.08+72.17%
5 qtrssince 2022-Q2
Decreased
0

META PLATFORMS INC-CLASS A

60,000$17.2M0.2%$192.94+44.91%
13 qtrssince 2020-Q2
Decreased
0

ARDAGH METAL PACKAGING S A

4.3M$16.2M0.2%$6.20-54.36%
8 qtrssince 2021-Q3
Decreased
0

ALPHABET INC-CL A

125,000$15M0.2%$89.37+32.27%
18 qtrssince 2019-Q1
Decreased
0

CHENIERE ENERGY INC

95,000$14.5M0.1%$154.28-4.32%
4 qtrssince 2022-Q3
Increased
48

APOLLO GLOBAL MANAGEMENT INC

185,000$14.2M0.1%$62.92+15.86%
3 qtrssince 2022-Q4
Increased
42

BRISTOL-MYERS SQUIBB CO

215,000$13.7M0.1%$46.49+21.06%
17 qtrssince 2019-Q2
Decreased
0
HBIHBI
CALL
Acquired

HANESBRANDS INC

2.4M$10.9M0.1%
Unchanged

UNITEDHEALTH GROUP INC

21,500$10.3M0.1%$454.49-11.77%
1 qtr
New
47

COMCAST CORP-CLASS A

240,000$10M0.1%$29.41+17.80%
18 qtrssince 2019-Q1
Unchanged
0
60,000$9.4M0.1%
1 qtr
New
39

WELLS FARGO & CO

200,000$8.5M0.1%$32.41+22.22%
14 qtrssince 2020-Q1
Decreased
0

GENERAL MOTORS CO

200,000$7.7M0.1%$40.47-8.05%
18 qtrssince 2019-Q1
Unchanged
0

ALLY FINANCIAL INC

200,000$5.4M0.1%$24.270.00%
1 qtr
New
38
$9.7B
AUM
31
Positions
Q2 2023
Filing
2.0/5
HI score
Quarterly 13F Value Change
+9%Q1'22$12.3B-8%Q2'22$11.3B-17%Q3'22$9.4B+14%Q4'22$10.7B-8%Q1'23$9.8B-1%Q2'23$9.7B
Activity profile
$ moved · Q2'23
New17%Increased61%Decreased21%Exited1%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.7 years
<1Q6%1-4Q16%1-2Y13%2Y+65%

LOEWS CORP manages $9.7B across 31 positions as of Q2 2023. Top holdings: CNA (96.9%), BERY (0.3%), APD (0.2%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2/5.0.

Q2 2023 Summary

Added 5 new positions, exited 1, increased 5, trimmed 14. Top move: CNA (INCREASED, conviction 63). Portfolio: $9.7B across 31 positions.

Top holdings by portfolio weight

Total AUM$10B
CNA96.87%
BERY0.28%
APD0.22%
HBI0.21%
INGR0.20%
LYB0.20%
HCA0.18%
META0.18%
AMBP0.17%
GOOGL0.15%
Other0.15%

Portfolio allocation by GICS sector

Sectors9
Financial Services97.29%
Unknown0.60%
Basic Materials0.52%
Healthcare0.47%
Communication Services0.43%
Consumer Cyclical0.25%
Consumer Defensive0.20%
Energy0.15%
Technology0.09%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L52
Conviction40
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
AVTRAVTRAVANTOR INC
Q1 2026 Q2 2026+1.2M shares+$10.3M
2Q
BLDRBLDRBUILDERS FIRSTSOURCE INC
Q1 2026 Q2 2026+500,000 shares+$41M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used